Patents by Inventor Michael Hollander

Michael Hollander has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ENGINEERED PROTEINS TO ENHANCE SENSITIVITY OF A CELL TO IL-2
    Publication number: 20260042808
    Abstract: Engineered proteins, polynucleotides encoding such proteins, and methods of use thereof are provided, which engineered proteins enhance the sensitivity of a cell to IL-2.
    Type: Application
    Filed: October 16, 2025
    Publication date: February 12, 2026
    Inventors: Kenan Christopher Garcia, Sean Parker, Jonathan Sockolosky, Michael Hollander
  • Engineered proteins to enhance sensitivity of a cell to IL-2
    Patent number: 12466868
    Abstract: Engineered proteins, polynucleotides encoding such proteins, and methods of use thereof are provided, which engineered proteins enhance the sensitivity of a cell to IL-2.
    Type: Grant
    Filed: September 1, 2023
    Date of Patent: November 11, 2025
    Assignees: The Board of Trustees of the Leland Stanford Junior University, Park Institute for Cancer Immunotherapy
    Inventors: Kenan Christopher Garcia, Sean Parker, Jonathan Sockolosky, Michael Hollander
  • ENGINEERED PROTEINS TO ENHANCE SENSITIVITY OF A CELL TO IL-2
    Publication number: 20240092855
    Abstract: Engineered proteins, polynucleotides encoding such proteins, and methods of use thereof are provided, which engineered proteins enhance the sensitivity of a cell to IL-2.
    Type: Application
    Filed: September 1, 2023
    Publication date: March 21, 2024
    Inventors: Kenan Christopher Garcia, Sean Parker, Jonathan Sockolosky, Michael Hollander
  • Engineered proteins to enhance sensitivity of a cell to IL-2
    Patent number: 11780899
    Abstract: Engineered proteins, polynucleotides encoding such proteins, and methods of use thereof are provided, which engineered proteins enhance the sensitivity of a cell to IL-2.
    Type: Grant
    Filed: December 5, 2018
    Date of Patent: October 10, 2023
    Assignees: The Board of Trustees of the Leland Stanford Junior University, Parker Institute for Cancer Immunotherapy
    Inventors: Kenan Christopher Garcia, Sean Parker, Jonathan Sockolosky, Michael Hollander
  • Engineered Proteins to Enhance Sensitivity of A Cell to IL-2
    Publication number: 20200385438
    Abstract: Engineered proteins, polynucleotides encoding such proteins, and methods of use thereof are provided, which engineered proteins enhance the sensitivity of a cell to IL-2.
    Type: Application
    Filed: December 5, 2018
    Publication date: December 10, 2020
    Inventors: Kenan Christopher Garcia, Sean Parker, Jonathan Sockolosky, Michael Hollander